Lone Hoffmann

🌟 Join Our HYBRID Course on IMRT and VMAT: Best practices and new trends! 🌟 ⏰ Don’t miss out and apply before the early deadline live course: 14 August 2024 and for the online course: 11 September 2024 👉Read more information and register : bit.ly/3W3eAZt #radonc

Ane Appelt @cancerphysicist reporting outcome of questionare on reporting in reirradiation at ReCOG. High ambitions for for treatment and reporting

Fantastic days at the ReCOG conference. @elivaos discussing deformable image registration for reirradiation

The RTQA group visited USZ and PSI (Switzerland). Through the exchange of treatment experiences, these visits are of great value to the PROTECT study and the participating sites. All with the common goal of improving the treatment of esophageal cancer. (protecttrial.eu)

First of the yearly RTQA meetings in the PROTECT trial. Great success with a lot of fantastic contributions and discussions. More than 40 participants. Thank you for joining. Looking forward to continued collaboration.

Thank you Line and thank you to all my "flash" colleagues in Aarhus for some wonderfull days at #FRPT2023

⭐ Rest up, recharge, and get ready for more tomorrow. 💙 See you bright and early for the final day of #FRPT2023

💙 Thank you for being a part of today's success—can't wait to continue sharing knowledge with you tomorrow. Until then, goodnight and see you soon! #FRPT2023

My colleague Lars Praestegaard gave a great presentation of our work on the use of current transformer in eFLASH dosimetry at Aarhus university hospital #FRPT2023

Fantastic overview on clinical FLASH effects by @BritaSingers #FRPT2023

Our new paper on the frontpage. Showing challenges in DIBH for some lung and oesophageal cancer patients

First 🇨🇭 oesophageal cancer patient enrolled into randomized PROTECT trial, comparing neoadjuvant Photon or Proton radiochemotherapy 👉 Strong collaboration between @psich_de and @Unispital_USZ @RadOncUSZ @CCCZ_USZ psi.ch/de/media/forsc…

Start of BiGART conference #BIGART2023. A lot og great talks. This one from Simon Thomsen on offline adaptive RT for lung cancer

End of a fantastic course: ESTRO IMRT. I would like to thank all partipants for all the interaction. Looking forward to next year. #ESTRO_RT

First day og ESTRO IMRT course. Particpants from 22 contries. We are in Turin - very nice city. Very excited to get started. Hope to get a lot of feed back from the students . #estro

Sådan💪- stor ros til Nationalt Forskningscenter for Stråleterapi for "Fremragende forskning, som bidrager til bedre strålebehandling af kræftpatienter i hele Danmark". Centret er blevet til med støtte fra #Knækcancer #dkforsk #sundpol cancer.dk/nyheder/stor-r…

Great and important talk on all the missing tools an "nice to have" tools in reirradiation. E.g the possibility to optimize new plan based on former plan in EQD2. @elivaos

More results from the DBCG trials. Much larger risk of breast endurance for former smokers. Presented by chief physicist Mette Skovhus Thomsen

Results from the ESTRO Physics reirradiation workshop 2022 showing large variety between dose accumulation in a large number of centres. Presented by @cancerphysicist and @elivaos

Congratulations professor Cai Grau. Recieving the Breur award during the opening ceremony of ESTRO.